[18F]MNI-1054

DRUG2 trials

Sponsors

Invicro

Conditions

Healthy VolunteersHealthy Volunteers (HV)

Early Phase 1

Assessment of [18F]MNI-1054 as a Marker for LSD1

CompletedNCT03695926

InvicroHealthy Volunteers (HV)

Start: 2018-08-09End: 2019-05-02Updated: 2019-05-23

Phase 1

Assessment of the Biodistribution and Safety of [18F]MNI-1054

CompletedNCT03719482

InvicroHealthy Volunteers

Start: 2018-10-05End: 2019-05-02Updated: 2019-05-23